Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Single Donor Human Whole Blood from Innovative Research was used in the following study:

 

Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Jungwhoi Lee, Jungsul Lee, Jae-Hoon Kim

Cancer Letters
1 March 2019

“…Pancreatic cancer remains one of the most dangerous cancers with a grave prognosis. We have reported that dual specificity phosphatise 28 (DUSP28) could be secreted in pancreatic cancer cells. . …To measure scattered DUSP28 in whole blood of pancreatic cancer patients, blood samples (ten from pancreatic cancer patients and sixteen from healthy individuals) were purchased from Innovative Research (Novi, MI, USA)…”

 

Related products available from Innovative Research also include: